Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$13.05 - $33.93 $5,820 - $15,132
-446 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$12.71 - $16.5 $5,668 - $7,359
446 New
446 $6,000

Others Institutions Holding GRAY

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About GRAYBUG VISION, INC.


  • Ticker GRAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,517,700
  • Market Cap $63.5M
  • Description
  • Graybug Vision, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the t...
More about GRAY
Track This Portfolio

Track Pinz Capital Management, LP Portfolio

Follow Pinz Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinz Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Pinz Capital Management, LP with notifications on news.